Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Owl Manor
AddedFeb 15, 2024
UpdatedJun 18, 2026
Owl Manor

Owl Manor

Series A

Owl Manor: A private medical device firm specializing in joint preservation and wound care for animals.

HQ
Warsaw, IN, US
Founded
2015
Overview
Compare
Fundraising
Employees

Owl Manor is a private medical device company focused on joint and soft tissue preservation for companion animals, specifically equine and canine. The company offers advanced joint lameness technologies and wound care devices, aiming to enhance the quality of life for animals through regenerative medicine therapies. Their product line includes Pro-Stride® APS, Restigen® PRP, and CenTrate® BMA, which leverage the animal's own body for healing.

Owl Manor has made significant strides in the veterinary field, particularly in managing equine lameness and orthopedic injuries. Their innovative approach and effective products have positioned them as a leader in animal regenerative medicine. Affiliated with Zoetis, a global animal health company, Owl Manor benefits from a strong network and resources, further amplifying their impact in the market.

Owl Manor - Similar Companies

PetVivo Holdings logo

PetVivo Holdings

petvivo.com

Equine Amnio Solutions logo

Equine Amnio Solutions

renovoequine.com

Gallant Pet logo

Gallant Pet

gallant.com

Vetherapy logo

Vetherapy

Night Owl Medical logo

Night Owl Medical

Owl biomedical logo

Owl biomedical

Equinext logo

Equinext

Otto logo

Otto

Bioventus logo

Bioventus

O2M Technologies logo

O2M Technologies

RenovoDerm logo

RenovoDerm

MedVet logo

MedVet

medvetforpets.com

MedcoVet logo

MedcoVet

medcovet.com

Wound Care Technologies logo

Wound Care Technologies

VetDC logo

VetDC

Owl Manor - Quick Facts

Who are Owl Manor's competitors?

Companies similar to Owl Manor include PetVivo Holdings, Equine Amnio Solutions, Gallant Pet and Vetherapy.

When was Owl Manor founded?

Owl Manor was founded in 2015.

Where is Owl Manor's headquarters located?

Owl Manor's headquarters is located in Warsaw, IN, US.

When was Owl Manor's last funding round?

Owl Manor's most recent funding round was for $1.2M (USD) in August 2016.

How much has Owl Manor raised to-date?

As of Aug 1, 2016, Owl Manor has raised a total of $1.2M (USD).

How many employees does Owl Manor have?

Owl Manor has 11 employees as of Feb 4, 2024.

Owl Manor - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified